as on October 22, 2025 at 7:38 pm IST
Day's Low
Day's High
0.49%
Downside
1.72%
Upside
52 Week's Low
52 Week's High
74.26%
Downside
16.18%
Upside
Check Adc Therapeutics Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$482.6M
EPS (TTM)
-1.525
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-126.1M
Revenue (TTM)
77.2M
Profit Margin
-220.00%
Return On Equity TTM
196900.00%
Compare market cap, revenue, PE, and other key metrics of Adc Therapeutics Sa with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $482.6M | -85.09% | NA | -220.00% | |
BUY | $64.4B | 252.94% | -505.15 | -12.96% | |
NA | $35.3B | NA | NA | -3.89% | |
BUY | $107.5B | 102.91% | 29.68 | 31.86% | |
BUY | $61.3B | 0.63% | 14.58 | 31.37% |
The Adc Therapeutics Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Adc Therapeutics Sa investment value today
Current value as on today
₹1,32,457
Returns
₹32,457
(+32.46%)
Returns from Adc Therapeutics Sa Stock
₹27,900 (+27.9%)
Dollar Returns*
₹4,557 (+4.56%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Adc Therapeutics Sa. Average target price of $8
Get share price movements and forecasts by analysts on Adc Therapeutics Sa.
What analysts predicted
49%UPSIDE
Target Price
$8
Current Price
$4.08
Analyzed by
12 Analysts
Target
$8.00
Adc Therapeutics Sa target price $8, a slight upside of 49% compared to current price of $4.08. According to 12 analysts rating.
Search interest for Adc Therapeutics Sa Stock has increased by 77% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:77% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, ADCT stock has moved up by 18.7%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 30.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 151.9%
Profit Down
Netprofit is down for the last 3 quarters, -30.72M → -56.64M (in $), with an average decrease of 36.2% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 23.03M → 18.83M (in $), with an average decrease of 18.2% per quarter
Organisation | Adc Therapeutics Sa |
Headquarters | BiopOle, Epalinges, Switzerland, 1066 |
Industry | Health Technology |
CEO | Dr. Ameet Mallik M.B.A., M.S. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Ameet Mallik M.B.A., M.S. | CEO & Director |
Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer |
Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer |
Dr. David S. Ege Ph.D. | Chief Technical Officer |
Ms. Marcy Graham | Investor Relations Officer |
Ms. Kristen Harrington-Smith | Chief Commercial Officer |
Mr. Jose I. Carmona M.B.A. | Chief Financial Officer |
Dr. Patrick van Berkel Ph.D. | Chief Scientific Officer |
Mr. Peter J. Graham Esq. | Secretary & Chief Legal Officer |
Ms. Kimberly Pope | Senior VP & Chief People Officer |
Adc Therapeutics Sa share price today is $4.08 as on . Adc Therapeutics Sa share today touched a day high of $4.15 and a low of $4.06.
Adc Therapeutics Sa share touched a 52 week high of $4.74 on and a 52 week low of $1.05 on . Adc Therapeutics Sa stock price today i.e. is trending at $4.08,which is 13.92% down from its 52 week high and 288.57% up from its 52 week low.
Adc Therapeutics Sa market capitalisation is $0.00T as on .
Indian investors can start investing in Adc Therapeutics Sa (ADCT) shares with as little as ₹87.755 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Adc Therapeutics Sa stock (as per the Rupee-Dollar exchange rate as on ).
Based on Adc Therapeutics Sa share’s latest price of $4.08 as on October 22, 2025 at 7:38 pm IST, you will get 2.4510 shares of Adc Therapeutics Sa. Learn more about
fractional shares .
Adc Therapeutics Sa stock has given -85.09% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?